Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuromyelitis Optica Spectrum Disorder Attack”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableUnknownNCT05605951
What this trial is testing

Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve

Who this might be right for
Demyelinating DiseasesMultiple SclerosisNeuromyelitis Optica Spectrum Disorder Attack+2 more
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738952
What this trial is testing

Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Kyushu University 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT07184840
What this trial is testing

Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital 110
Not applicableLooking for participantsNCT07762872
What this trial is testing

Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)
Junwei Hao, MD 50
Post-approval studies (Phase 4)Looking for participantsNCT07410039
What this trial is testing

Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Chinese PLA General Hospital 200
Not applicableUnknownNCT04101058
What this trial is testing

Treatment Response Among Chinese Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Third Affiliated Hospital, Sun Yat-Sen University 200
Large-scale testing (Phase 3)UnknownNCT00004645
What this trial is testing

Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone

Who this might be right for
Acute Disseminated EncephalomyelitisDevic's SyndromeMarburg's Variant of Multiple Sclerosis+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 22
Testing effectiveness (Phase 2)WithdrawnNCT06673394
What this trial is testing

Eculizumab For Acute Attack of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital
Testing effectiveness (Phase 2)UnknownNCT04064944
What this trial is testing

Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Third Affiliated Hospital, Sun Yat-Sen University 144
Not applicableEnded earlyNCT04131764
What this trial is testing

Diagnosis of ON With or Without MS or NMOSD

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum Disorder AttackNeuromyelitis Optica Spectrum Disorder Relapse+2 more
Jagannadha R Avasarala 112
Testing effectiveness (Phase 2)UnknownNCT06497374
What this trial is testing

FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderNMO Spectrum Disorder
Tianjin Medical University General Hospital 63
Early research (Phase 1)WithdrawnNCT02087813
What this trial is testing

Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses

Who this might be right for
Neuromyelitis Optica
Stanford University